???global.info.a_carregar???
I hold a BSc (2011) and an MSc (2013) in Biochemistry from the University of Porto. My MSc thesis integrated medicinal chemistry and biochemistry, focusing on developing mitochondria-targeted antioxidants for treating oxidative stress-related pathologies. Before pursuing a PhD, I worked as an R&D assistant at MA Silva & Cork in 2015, where I utilized a portable electronic nose to address cork quality control issues related to odor complaints. Additionally, I developed crystallography skills under the mentorship of Luis Gales at ICBAS-UP, working on a project aimed at mitigating paraquat toxicity. I was awarded research fellowships to explore new therapies for nonalcoholic fatty liver disease (NAFLD) and undertook a PhD in Biomedicine and Experimental Biology under Paulo Oliveira at the University of Coimbra. My PhD research involved validating a novel mitochondria-targeted antioxidant for NAFLD and elucidating its cellular mechanism. In 2022, my PhD thesis was recognized as one of the top five at UC for its excellence. In 2019, I gained international experience by spending several months at CLADE in Esslingen, Germany, as part of a European collaboration to develop non-invasive profiling of mitochondrial function in NAFLD using infrared spectroscopy. Following my PhD, I secured a postdoctoral position at ICBR-UC, where I explored the therapeutic potential of medicinal plants for NAFLD and conducted a proof-of-concept study on mitochondria-targeted polyphenols for NAFLD treatment. This role enhanced my project management and team leadership skills. In July 2023, I transitioned to cancer research by joining the Expression Regulation in Cancer group at i3S in Porto as a Junior Researcher. I am currently engaged in a project focusing on the clinical and financial management of hereditary diffuse gastric cancer (HDGC) within the framework of the i3S-coordinated European consortium PREVENTABLE. Throughout my career, I have participated in 11 funded research projects and published 17 papers and a book chapter in international peer-reviewed journals, with eight as first or second author. I have presented 11 oral and 14 poster presentations at national and international meetings, earning one best talk and four best poster awards, along with six travel grants. I have collaborated with leading experts in oxidative stress (Mariusz R. Wieckowski, Poland), mitochondrial biology (Hans Zischka, Germany), medicinal chemistry (Fernanda Borges, Porto), and lipid metabolism (D. John Jones, Coimbra). My involvement in the CLADE lab in Germany facilitated innovative research utilizing infrared spectroscopy for analyzing NAFLD patients' plasma profiles. I have also actively contributed to science dissemination, serving on the organizing committees of three scientific conferences, co-supervising three MSc theses, four bachelor student internships, and three visiting students. Additionally, I have been invited to peer-review for several scientific journals and have participated in outreach activities through CNC's educational programs. My goal is to continue performing competitive research at the highest level and transition into an independent researcher position within the next six years.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Ricardo Fernando Santos Amorim

Nomes de citação

  • Amorim, Ricardo

Identificadores de autor

Ciência ID
B11D-8714-A7C5
ORCID iD
0000-0002-5177-049X
Scopus Author Id
57195236911

Endereços de correio eletrónico

  • ricardo.amorim@i3s.up.pt (Profissional)

Telefones

Telemóvel
  • 916960211 (Pessoal)

Moradas

  • R. Alfredo Allen 208, 4200-135, Paranhos , Porto , Portugal (Profissional)
  • Rua Camões Nº31, Costa - Mansores, 4540-416, Arouca, Arouca, Portugal (Pessoal)

Domínios de atuação

  • Ciências Naturais - Ciências Biológicas - Bioquímica
  • Ciências Naturais - Ciências Biológicas - Biologia Celular
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular
  • Ciências Médicas e da Saúde - Medicina Básica - Química Médica
  • Ciências Médicas e da Saúde - Medicina Básica - Toxicologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C2) Utilizador independente (B2) Utilizador proficiente (C1)
Espanhol; Castelhano Utilizador elementar (A2) Utilizador elementar (A2) Utilizador elementar (A2) Utilizador elementar (A2)
Formação
Grau Classificação
2024/10 - 2024/10
Concluído
 5th Course on Hereditary Cancer Genetics - Virtual Edition (Especialização pós-bacharelato)
European Society of Human Genetics, Áustria
2017/11 - 2022/04/21
Concluído
 Experimental Biology and Biomedicine (BEB) (Doctor)
Especialização em Molecular, Cellular and Developmental Biology
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
2019/01/07 - 2019/01/18
Concluído
 II Modular Training in Laboratory Animal Science - Advanced course (Especialização pós-licenciatura)
Universidade de Coimbra, Portugal
2011 - 2013
Concluído
 Biochemistry (Master)
Especialização em Sem especialização
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
""Development of mitochondria-targeted antioxidants: innovative therapeutic strategy for neurodegenerative diseases"" (TESE/DISSERTAÇÃO)
 17/20
2008 - 2011
Concluído
 Biochemistry (Bachelor)
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
""Stimulated gastrointestinal digestion of Port wines. Effect on human colon cancer cell lines proliferation"" (TESE/DISSERTAÇÃO)
 14/20
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/07/01 - Atual Investigador (Investigação) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2022/06/01 - 2023/05/31 Pós-doutorado (Investigação) Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal
2019/09 - 2019/12 Investigador visitante (Investigação) CLADE GmbH , Alemanha

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2017/11/01 - 2022/04/21 pHD candidate Fundação para a Ciência e a Tecnologia, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2017/07 - 2017/10 Research Fellow (BI) Fellowship - Integration of research project "MitoBOOST: A Next-Generation Therapeutics for Non-Alcoholic Fatty Liver Disease Based on Smart Antioxidants Delivery to Mitochondria" Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2017/01 - 2017/06 Research Fellow (BI) Fellowship - Integration of research project "MitoBOOST: A Next-Generation Therapeutics for Non-Alcoholic Fatty Liver Disease Based on Smart Antioxidants Delivery to Mitochondria" Universidade do Porto Faculdade de Ciências, Portugal
2014/04 - 2015/05 Research Fellow (BI) Fellowship - Integration of research and development project entitle "Identifying the source of an odor complaint using a portable electronic nose" Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2014 - 2015 R&D associate M.A.SILVA - CORTIÇAS, S.A., Portugal
Projetos

Bolsa

Designação Financiadores
2023 - Atual Remodelação metabólica e mitocondrial induzida pela atividade física em fibroblastos de pacientes com a Doença de Parkinson
2022.01232.PTDC
Outra
Associação para a Inovação e Desenvolvimento da FCT
Em curso
2021/01/01 - Atual BraveHEART: Improving Nature by Addressing Bioactiv Dietary Polyphenols to Mitochondria for the Protection of Cardiac Complications in Non-Alcoholic Fatty Liver Disease
EXPL/BIA-BQM/1361/2021
Bolseiro de Doutoramento
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
2025/01 - 2026/06 Adipocyte Browning: the missing link for peritoneal metastasis in diffuse gastric cancer [BROWNIE]
2023.11680.PEX
Investigador responsável
Fundação para a Ciência e a Tecnologia
2023/03 - 2025/03 MitoTARGET4AD: Improving Nature for a Novel Disruptive Treatment for Alzheimer's Disease
2022.15117.CBM
Investigador Pós-doutorado
Em curso
2019/06/01 - 2023 CôaMedPlants: Preservation of natural and cultural heritage and scientific validation of practices with medicinal plants from Côa Valley
COA/BRB/0019/2019
Bolseiro de Pós-Doutoramento
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Em curso

Projeto

Designação Financiadores
2022/06 - Atual MitoBOOST v2.0 - A Proof of Concept for the Use of Mitochondria-Targeted Polyphenols to Treat Non-Alcoholic Fatty Liver Disease
V2.0 IT137-22-151
Investigador Pós-doutorado
Comissão de Coordenação e Desenvolvimento Regional do Centro (CCDRC)
2021 - Atual Human Neuronal Cells Differentiated from Urine-derived Stem Cells as a Platform for Personalized Medicine in Amyotrophic Lateral Sclerosis
PTDC/BTM-ORG/0055/2021
Outra
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Em curso
2023/07/01 - 2025/12/31 CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE
101095483
10.3030/101095483
Investigador
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 European Commission
Em curso
2017/06/01 - 2022/08/31 mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease
734719
10.3030/734719
Bolseiro de Cientista Convidado
European Commission
Concluído
2018/07/26 - 2021/07/25 Uso de fitoquímicos redox-activos para desencadear a hormesis mitocondrial: Desenvolvimento de uma nova geração de ingredientes para a cosmética
PTDC/BIA-MOL/28607/2017
Universidade do Porto, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2018/07/26 - 2021 SkinSHIELD - Redox-active phytochemicals triggering mitochondrial hormesis: developing a new generation of cosmetic active ingredients
POCI-01-0145-FEDER-028607
Bolseiro de Doutoramento
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Concluído
2019/01/01 - 2019/12/31 CNC. IBILI
UID/NEU/04539/2019
Bolseiro de Integração na Investigação
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Universidade de Coimbra, Portugal

Universidade de Coimbra Instituto de Ciências Nucleares Aplicadas à Saúde, Portugal

Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2019/01/01 - 2019/12/31 Centro de Investigação em Química da Universidade do Porto (Chemistry Research Center of the University of Porto)
UID/QUI/00081/2019
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Centro de Investigação em Química, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2017/01/01 - 2017/10/31 MitoBOOST: A Next-Generation Therapeutics for Non-Alcoholic Fatty Liver Disease Based on Smart Antioxidant Delivery to Mitochondria Pathophysiology
PTDC/DTP-FTO/2433/2014
Bolseiro de Investigação
Associação para a Inovação e Desenvolvimento da FCT
Concluído
Produções

Publicações

Artigo em revista
  1. Amorim, Ricardo; Soares, Pedro; Chavarria, Daniel; Benfeito, Sofia; Cagide, Fernando; Teixeira, José; Oliveira, Paulo J.; Borges, Fernanda. "Decreasing the Burden of Non-Alcoholic Fatty Liver Disease: from Therapeutic Targets to Drug Discovery Opportunities". European Journal of Medicinal Chemistry (2024): 116723. http://dx.doi.org/10.1016/j.ejmech.2024.116723.
    10.1016/j.ejmech.2024.116723
  2. Amorim, Ricardo; Magalhães, Carina C.; Benfeito, Sofia; Cagide, Fernando; Tavares, Ludgero C.; Santos, Katia; Sardão, Vilma A.; et al. "Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN6 sensitizes cisplatin lung anticancer therapy due to a remodeling of energy metabolism". Biochemical Pharmacology 219 (2024): 115953. http://dx.doi.org/10.1016/j.bcp.2023.115953.
    10.1016/j.bcp.2023.115953
  3. Amorim, Ricardo; Magalhães, Carina C.; Borges, Fernanda; Oliveira, Paulo J.; Teixeira, José. Autor correspondente: Amorim, Ricardo. "From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria". Biology 12 4 (2023): 595. http://dx.doi.org/10.3390/biology12040595.
    10.3390/biology12040595
  4. Ricardo Amorim; Inês C.M. Simões; José Teixeira; Fernando Cagide; Yaiza Potes; Pedro Soares; Adriana Carvalho; et al. "Mitochondria-targeted anti-oxidant AntiOxCIN4 improved liver steatosis in Western diet-fed mice by preventing lipid accumulation due to upregulation of fatty acid oxidation, quality control mechanism and antioxidant defense systems". Redox Biology 55 (2022): 102400-102400. http://dx.doi.org/10.1016/j.redox.2022.102400.
    10.1016/j.redox.2022.102400
  5. Marta Afonso; Islam T; Magusto J; Amorim R; Lenoir V; F Simões R; Teixeira J; et al. "RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease.". Hepatology (Baltimore, Md.) (2022): https://doi.org/10.1002/hep.32756.
    10.1002/hep.32756
  6. Amorim, Ricardo; Cagide, Fernando; Tavares, Ludgero C.; Simões, Rui F.; Soares, Pedro; Benfeito, Sofia; Baldeiras, Inês; et al. "Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage". Free Radical Biology and Medicine 179 (2022): 119-132. http://dx.doi.org/10.1016/j.freeradbiomed.2021.12.304.
    10.1016/j.freeradbiomed.2021.12.304
  7. Simões, Inês C. M.; Amorim, Ricardo; Teixeira, José; Karkucinska-Wieckowska, Agnieszka; Carvalho, Adriana; Pereira, Susana P.; Simões, Rui F.; et al. "The Alterations of Mitochondrial Function during NAFLD Progression An Independent Effect of Mitochondrial ROS Production". International Journal of Molecular Sciences 22 13 (2021): 6848. http://dx.doi.org/10.3390/ijms22136848.
    10.3390/ijms22136848
  8. Amorim, Ricardo; Simões, Inês C. M.; Veloso, Caroline; Carvalho, Adriana; Simões, Rui F.; Pereira, Francisco B.; Thiel, Theresa; et al. "Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells". Nutrients 13 5 (2021): 1723. http://dx.doi.org/10.3390/nu13051723.
    10.3390/nu13051723
  9. Teixeira, José; Basit, Farhan; Willems, Peter H.G.M.; Wagenaars, Jori A.; van de Westerlo, Els; Amorim, Ricardo; Cagide, Fernando; et al. "Mitochondria-targeted phenolic antioxidants induce ROS-protective pathways in primary human skin fibroblasts". Free Radical Biology and Medicine 163 (2021): 314-324. http://dx.doi.org/10.1016/j.freeradbiomed.2020.12.023.
    10.1016/j.freeradbiomed.2020.12.023
  10. Catarina Oliveira; Donatella Bagetta; Fernando Cagide; José Teixeira; Ricardo Amorim; Tiago Silva; Jorge Garrido; et al. "Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents". European Journal of Medicinal Chemistry 174 (2019): 116-129. https://doi.org/10.1016/j.ejmech.2019.04.026.
    10.1016/j.ejmech.2019.04.026
  11. Benfeito, S.; Oliveira, C.; Fernandes, C.; Cagide, F.; Teixeira, J.; Amorim, R.; Garrido, J.; et al. "Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction". European Journal of Medicinal Chemistry 167 (2019): 525-545. http://dx.doi.org/10.1016/j.ejmech.2019.01.055.
    10.1016/j.ejmech.2019.01.055
  12. Carlos Fernandes; Sofia Benfeito; Ricardo Amorim; José Teixeira; Paulo J. Oliveira; Fernando Remião; Fernanda Borges. "Desrisking the Cytotoxicity of a Mitochondriotropic Antioxidant Based on Caffeic Acid by a PEGylated Strategy". Bioconjugate Chemistry 29 8 (2018): 2723-2733. https://doi.org/10.1021%2Facs.bioconjchem.8b00383.
    10.1021/acs.bioconjchem.8b00383
  13. Catarina Oliveira; Fernando Cagide; José Teixeira; Ricardo Amorim; Lisa Sequeira; Francesco Mesiti; Tiago Silva; et al. "Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors". Frontiers in Chemistry 6 (2018): https://doi.org/10.3389%2Ffchem.2018.00126.
    10.3389/fchem.2018.00126
  14. José Teixeira; Catarina Oliveira; Fernando Cagide; Ricardo Amorim; Jorge Garrido; Fernanda Borges; Paulo J. Oliveira. "Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid". Journal of Enzyme Inhibition and Medicinal Chemistry 33 1 (2018): 567-576. https://doi.org/10.1080%2F14756366.2018.1442831.
    10.1080/14756366.2018.1442831
  15. Teixeira, José; Amorim, Ricardo; Santos, Katia; Soares, Pedro; Datta, Sandipan; Cortopassi, Gino A.; Serafim, Teresa L.; et al. "Disruption of mitochondrial function as mechanism for anti-cancer activity of a novel mitochondriotropic menadione derivative". Toxicology 393 (2018): 123-139. http://dx.doi.org/10.1016/j.tox.2017.11.014.
    10.1016/j.tox.2017.11.014
  16. Teixeira, José; Oliveira, Catarina; Amorim, Ricardo; Cagide, Fernando; Garrido, Jorge; Ribeiro, José A.; Pereira, Carlos M.; et al. "Development of hydroxybenzoic-based platforms as a solution to deliver dietary antioxidants to mitochondria". Scientific Reports 7 1 (2017): http://dx.doi.org/10.1038/s41598-017-07272-y.
    10.1038/s41598-017-07272-y
  17. Gales, Luís; Amorim, Ricardo; Afonso, Carlos Manuel M.; Carvalho, Félix; Dinis-Oliveira, Ricardo Jorge. "Decreasing the toxicity of paraquat through the complexation with sodium salicylate: Stoichiometric analysis". Toxicology 336 (2015): 96-98. http://dx.doi.org/10.1016/j.tox.2015.08.005.
    10.1016/j.tox.2015.08.005
Capítulo de livro
  1. Amorim, Ricardo; Benfeito, Sofia; Teixeira, José; Cagide, Fernando; Oliveira, Paulo J.; Borges, Fernanda. "Targeting Mitochondria: The Road to Mitochondriotropic Antioxidants and Beyond". In Mitochondrial Biology and Experimental Therapeutics, 333-358. Springer International Publishing, 2018.
    10.1007/978-3-319-73344-9_16
Poster em conferência
  1. Amorim, Ricardo; Liliana Sousa; Luzia Garrido; Sara P Pereira; Lucybell Moreira; M. I. Carvalho; Ana Azevedo; et al. "Optimized Care Pathways and Price Allocation in CDH1-Associated Hereditary Diffuse Gastric Cancer". Trabalho apresentado em Charting the economics of hereditary cancer: from theory to real world data, 2024.
  2. SB Pereira; L Sousa; R Amorim; PREVENTABLE Consortium; C Oliveira. "PREVENTABLE - CANCER PREVENTION VS. TREATMENT IN RARE TUMOUR RISK SYNDROMES". Trabalho apresentado em Charting the economics of hereditary cancer: from theory to real world data, 2024.
  3. Amorim, Ricardo; Liliana Sousa; Luzia Garrido; Sara P Pereira; Lucybell Moreira; M. I. Carvalho; Manuela Baptista; et al. "Refined Cost Allocation Framework for Optimized Pathways of Care in CDH1-Linked Hereditary Diffuse Gastric Cancer Syndrome". Trabalho apresentado em 5th International Gastric Cancer Linkage Consortium, 2024.
  4. SB Pereira; L Sousa; Ricardo Amorim; Luzia Garrido; P Boaventura; Bárbara Peleteiro; M Fernandes; et al. "PREVENTABLE - CANCER PREVENTION VS. TREATMENT IN RARE TUMOUR RISK SYNDROMES: INSIGHTS FROM HDGC AND BEYOND". Trabalho apresentado em 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting, 2024.
  5. Carina Magalhães; Ricardo Amorim; Sofia Benfeito; Fernando Cagide; Ludgero C. Tavares; Vilma A. Sardão; John G. Jones; et al. "Repurposing the effects of decyl-TPP mitochondriotropic caffeic acid antioxidant AntiOxCIN6: The impact of rewiring mitochondrial metabolism on cisplatin anticancer therapy". Trabalho apresentado em 58th Annual meeting of the European Society for Clinical Investigation, “Connecting the Dots: The Power of Integrative Medicine, 2024.
  6. São José C.; Ferreira M; Cordova L.; Pedro A.; Santos R.; Amorim R.; André A.; et al. "Looking beyond coding mutations: the role of regulatory noncoding sequences in hereditary diffuse gastric cancer". Trabalho apresentado em The 57th European Human Genetics Conference, 2024.
  7. Carina Magalhães; Ricardo Amorim; Ana I. Duarte; Adriana Carvalho; Susana P. Pereira; Luís Grilo; Débora Mena; et al. "Mitochondria-targeted antioxidant AntiOxBEN2 improved liver steatosis in male and female mice fed with high-fat high-sugar (HFHS) diet". Trabalho apresentado em BEB day 2024, 2024.
  8. Heloísa Gerardo; Ricardo Amorim; Inês C.M. Simões; Cláudia Cavadas; Mariusz R. Wieckowski; Paulo J. Oliveira; Mário Grãos; José Teixeira. "Metabolic Syndrome’s Brain Twist: Exploring the interplay of metabolism and mechanotransduction". Trabalho apresentado em BEB day 2024, 2024.
  9. Heloísa Gerardo; Ricardo Amorim; Inês C.M. Simões; Cláudia Cavadas; Mariusz R. Wieckowski; Paulo J. Oliveira; Mário Grãos; José Teixeira. "Síndrome metabólica afeta de forma diferente o metabolismo e a rigidez do tecido cerebral: Dados de estudos in vitro e in vivo". Trabalho apresentado em 20º Congresso Português de Diabetes, 2024.
  10. Carina Magalhães; Ricardo Amorim; Ana I. Duarte; Adriana Carvalho; Susana P. Pereira; Luís Grilo; Débora Mena; et al. "O impacto do antioxidante mitocondriotrópico AntiOxBEN2 na esteatose hepática de ratinhos no contexto de Fígado Gordo Não-Alcoólico". Trabalho apresentado em 20º Congresso Português de Diabetes, 2024.
  11. Ricardo Amorim; Catarina Melim; Mário Pedro Marques; Carla Varela; Maria Inês Dias; Lillian Barros; José Teixeira; Paulo J. Oliveira; Célia Cabral. "QUISETUM RAMOSISSIMUM DESF. DO VALE DO CÔA (PORTUGAL) PREVINE A ACUMULAÇÃO LIPÍDICA E A DISFUNÇÃO MITOCONDRIAL INDUZIDA PELO ÁCIDO PALMÍTICO EM CÉLULAS HEPÁTICAS HUMANAS". Trabalho apresentado em 20º Congresso Português de Diabetes, 2024.
  12. Caroline Veloso; Carina Magalhães; Sofia Benfeito; Fernando Cagide; Rafael Silveira; Ivana Djedovic; Vera M. Mendes; et al. "Promissing effects of itochondriotropic anioxidant AntiOxCIN4 on cardiac metabolism in Western Diet-induced Metabolic Syndrome.". Trabalho apresentado em IV Metabolism, Ageing & Disease (MAD) Meeting - Disease & Therapeutics: from the Past to Future, 2024.
  13. Gerardo, Heloísa; Ricardo Amorim; Cláudia Cavadas; Mariusz R. Wieckowski; Paulo J. Oliveira; Mário Grãos; José Teixeira. "Brain stiffness alterations in Metabolic syndrome phenotype: A comprehensive exploration of metabolism and mechanotransduction crosstalk". Trabalho apresentado em IV Metabolism, Ageing & Disease (MAD) Meeting - Disease & Therapeutics: from the Past to Future, 2024.
  14. Bruna Isidoro; Caroline Veloso; Ricardo Amorim; Inês C.M. Simões; Sofia Benfeito; Fernando Cagide; Agnieszka Karkucinska-Wieckowska; et al. "Effects of AntiOxCIN4 on mitochondrial metabolism and oxidative stress of adipose tissue in a mouse model for Western Diet-induced metabolic syndrome". Trabalho apresentado em IV Metabolism, Ageing & Disease (MAD) Meeting - Disease & Therapeutics: from the Past to Future, 2024.
  15. Melim, Catarina; Amorim, Ricardo; Marques, Mário Pedro; Varela, Carla; Dias, Maria Inês; Barros, Lillian; Teixeira, José; Oliveira, Paulo J.; Cabral, Célia. "Efeito hepatoprotetor de plantas do Vale do Côa (Portugal) num modelo celular de doença do fígado gordo não alcoolico (DFGNA)". Trabalho apresentado em XXVII Encontro Luso Galego de Química, 2023.
  16. Amorim, Ricardo; Catarina Melim; Mário Pedro Marques; Carla Varela; Maria Ines Dias; Lillian Barros; José Teixeira; Paulo J. Oliveira; Célia Cabral. "Protective Effects of Equisetum ramosissimum Desf. against Palmitic Acid-Induced Lipid Accumulation and Mitochondrial Dysfunction in Human HepG2 cells". Trabalho apresentado em 57th Annual Scientific Meeting of the European Society for Clinical Investigation, 2023.
  17. Susana Alarico; Mariana Afonso; André Alves; Sandra Amaral; Ricardo Amorim; Emanuel Candeias; Maria Cardoso; et al. "One path for sustainable research". Trabalho apresentado em EU-LIFE Community Meeting 2023, 2023.
  18. Amorim, Ricardo; Ines CM Simoes; José Teixeira; Pedro Soares; Yaiza Potes; Sofia Benfeito; Ludgero C. Tavares; et al. "Mitochondria-targeted antioxidant AntiOxCIN4 prevents hepatic steatosis by enhancing mitochondrial function and autophagy in Western diet (WD)-fed mice". Trabalho apresentado em MitoPorto - Mitochondrial physiology, redox biology, and genetics, 2023.
  19. Grilo, Luís F.; Tocantins, Carolina; Diniz, Mariana S.; Martins, João D.; Mena, Débora; Amorim, Ricardo; Jelena Stevanovic-Silva; et al. "Modulação na comunicação endócrina fígado-tecido adiposo e no estado redox ao longo do envelhecimento da descendência pela prática de exercício materno durante uma gestação obesogénica". Trabalho apresentado em 9º Congresso Portugês de Diabetes,, 2023.
  20. Carina Magalhães; Caroline Veloso; Rafael Silveira; Ivana Djedovic; Vera M. Mendes; Agnieszka Karkucinska-Wieckowska; Amorim, Ricardo; et al. "Antioxidante mitocondriotrópico AntiOxCIN4 previne as alterações cardíacas no contexto da doença do fígado gordo não-alcóolico". Trabalho apresentado em 19º Congresso Portugês de Diabetes, 2023.
  21. Gerardo, Heloísa; Amorim, Ricardo; Inês C.M. Simões; Cláudia Cavadas; Wieckowski, Mariusz; Paulo J. Oliveira; Mário Grãos; José Teixeira. "O impacto da síndrome metabólica na interação entre metabolismo mitocondrial e mecanotransdução em cérebros de murganhos sujeitos a uma dieta ocidental". Trabalho apresentado em 19º Congresso Portugês de Diabetes, 2023.
  22. Amorim, Ricardo; Carina Magalhães; Sofia Benfeito; Ludgero C. Tavares; Inês Baldeiras; John G. Jones; Fernanda Borges; Paulo J. Oliveira. "The mitochondriotropic antioxidant based on caffeic acid AntiOxCIN6 induces a Shift in metabolic profile towards a more glycolytic phenotype: Implications for lung cancer therapy". Trabalho apresentado em BEB day, 2023.
  23. Amorim, Ricardo; José Teixeira; Sofia Benfeito; Fernando Cagide; Pedro Soares; Fernanda Borges; Paulo J. Oliveira. "Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage". Trabalho apresentado em BEB day, 2023.
  24. Heloísa Gerardo; Amorim, Ricardo; Inês C.M. Simões; Cláudia Cavadas; Wieckowski Mariusz R.; Paulo J. Oliveira; Mário Grãos; José Teixeira. "Crosstalk between mechanotransduction and mitochondrial metabolism in the brain of Western diet-fed mice". Trabalho apresentado em BEB day, 2023.
  25. Amorim, Ricardo; Ines CM Simoes; José Carlos Santos Teixeira; Pedro Soares; Yaiza Potes; Fernando Cagide; Sofia Benfeito; et al. "Mitochondriotropic antioxidant AntiOxCIN4 improves mitochondrial function and prevents Non-Alcoholic Fatty Liver (NAFL)-associated autophagic blockage in Western diet (WD)-fed mice". Trabalho apresentado em 56th Annual Meeting of the European Society for Clinical Investigation, 2022.
  26. Amorim, Ricardo; Inês C.M. Simões; José Teixeira; Yaiza Potes; Pedro Soares; Adriana Marques-Carvalho; Ludgero Tavares; et al. "Mitochondria-targeted antioxidant based on caffeic acid AntiOxCIN4 prevented hepatic lipid accumulation by avoided Western Diet-induced autophagic blockage". Trabalho apresentado em NAFLD summit, 2021.
  27. Inês MSimões; Amorim, Ricardo; José Teixeira; A. Karkucinska-Wieckowska; Paulo J. Oliveira; Mariuz R. Wieckowski. "Time dependent effect of western diet on mitochondrial physiology in a mouse model of non-alcoholic fatty liver disease". Trabalho apresentado em 55th ESCI Annual Scientific Meeting, 2021.
  28. Amorim, Ricardo; José Teixeira; Fernando Cagide; Fernanda Borges; Paulo J. Oliveira. "Decrypting the Nrf2-dependent antioxidant mechanism of action behind the beneficial effects of the mitochondriotropic cinnamic acid AntiOxCIN4". Trabalho apresentado em 55th ESCI Annual Scientific Meeting, 2021.
  29. Amorim, Ricardo; Inês Simões; Caroline Veloso; Adriana Carvalho; Rui F. Simões; Theresa Thiel; Catarina M. Morais; et al. "High fat vs High sugar: the role of mitochondria on time-dependent hepatocellular cytotoxic effects". Trabalho apresentado em 54th Annual Meeting of the European Society for Clinical Investigation, 2020.
  30. Catarina Oliveira; Donatella Bagetta; Fernando Cagide; José Teixeira; Tiago Silva; Fernando Remião; Eugenio Uriarte; et al. "Benzoic acid-derived Nitrones: a new class of acetylcholinesterase inhibitors and potential neuroprotective agents". Trabalho apresentado em Meeting of the Paul Ehrlich Euro-PhD Network - MuTaLig COST action, 2019.
  31. Pedro Soares; Catarina Oliveira; Sofia Benfeito; Fernando Cagide; Carlos Fernandes; Amorim, Ricardo; Paulo J. Oliveira; Fernanda Borges. "From nature inspiration to multi-target small molecules: upgrading the activity of dietary cinnamic". Trabalho apresentado em Meeting of the Paul Ehrlich Euro-PhD Network - MuTaLig COST action, 2019.
  32. Amorim, Ricardo; José Teixeira; Sofia Benfeito; Fernando Cagide; Fernando Borges ; Paulo J. Oliveira. "Effects of mitochondria-targeted antioxidants in human hepatic cells: a possible therapy for hepatic steatosis?". Trabalho apresentado em 3rd Annual Meeting of COST Action CA15135, 2018.
  33. Fernando Cagide; Sofia Benfeito; Catarina Oliveira; Carlos Fernandes; José Teixeira; Ricardo Amorim; Jorge Garrido; et al. "Fine-tuning the neuroprotective and blood-brain barrier permeability profile of dietary based mitochondria-targeted antioxidants". Trabalho apresentado em 3rd Annual Meeting of COST Action CA15135, 2018.
  34. Carlos Fernandes; Sofia Benfeito; Amorim, Ricardo; José Teixeira; Paulo J. Oliveira; Fernando Remião; Fernanda Borges. "Modulating the cytotoxicity of a mitochondriotropic antioxidant by a flexible PEGylation strategy". Trabalho apresentado em 3rd Annual Meeting of COST Action CA15135, 2018.
  35. Catarina Oliveira; Fernando Cagide; José Teixeira; Amorim, Ricardo; Tiago Silva; Jorge Garrido; Fernando Remião; et al. "Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors". Trabalho apresentado em 3rd Annual Meeting of COST Action CA15135, 2018.
  36. José Teixeira; Ricardo Amorim; Sofia Benfeito; Fernando Cagide; Paulo J. Oliveira; Fernanda Borges. "Mitochondriotropic cinnamic acid antioxidants improves steatosis in a Non-Alcoholic Fatty Liver Disease (NAFLD) cell model". Trabalho apresentado em 2nd MitoPORTO, 2018.
  37. Amorim, Ricardo; José Teixeira; Inês Baldeias; Sofia Benfeito; Fernando Cagide; Jorge Garrido; Paulo J. Oliveira; Fernanda Borges. "Mitochondriotropic cinnamic acid antioxidants increase cellular stress responses in HepG2 cells: involvement of (mt)ROS signaling?". Trabalho apresentado em 2nd MitoPORTO, 2018.
  38. José Teixeira; Ricardo Amorim; Carreira, Rodrigo; Sofia Benfeito; Fernando Cagide; Paulo J. Oliveira; Fernanda Borges. "Mitochondria-targeted cinnamic antioxidants incresae celular stress response through modulation of mitochondria function/activity". Trabalho apresentado em MuTaLig COST action, Universidad de la Laguna, 2018.
  39. José Teixeira; Ricardo Amorim; Katia Santos; Pedro Soares; Teresa Serafim; Vilma A. Sardão; Jorge Garrido; Fernanda Borges; Paulo J. Oliveira. "In vitro characterization of potential biological applications of MitoK3, a novel mitochondriotropic menadione derivative". Trabalho apresentado em In EpiChemBio and MuTaLig COST actions joint meeting, Portuguese Oncology Institute of Porto (IPO Porto), 2017.
  40. Carlos Fernandes; Amorim, Ricardo; José Teixeira; Paulo J. Oliveira; Fernando Remião; Fernanda Borges. "Synthesis of a mitochondriotropic antioxidante based on pegylation process". Trabalho apresentado em In EpiChemBio and MuTaLig COST actions joint meeting, Portuguese Oncology Institute of Porto (IPO Porto), 2017.
  41. José Teixeira; Amorim, Ricardo; Katia Santos; Pedro Soares; Vilma A. Sardão; Jorge Garrido; Fernanda Borges; Paulo J. Oliveira. "Improvement of menadione cytotoxic potential by a mitochondria targeted strategy". Trabalho apresentado em In MitoPorto: Advances in Mitochondrial Research International Symposium, 2017.
  42. Amorim, Ricardo; José Teixeira; Sofia Benfeito; Fernando Cagide; Jorge Garrido; Paulo J. Oliveira; Fernanda Borges. "Effects of different targeting cations on the toxicity profile of mitochondriotropic-hydroxycinnamic antioxidants". Trabalho apresentado em In MitoPorto: Advances in Mitochondrial Research International Symposium, 2017.
  43. Mesquita, Cátia; Claudia Deus; Magdalena Lebiedzinska-Arciszewska; Jan Suski; Massimo Bonora; Caroline Veloso; Sonia Pinho; et al. "Cytotoxicity of Hyperglycemia on H9c2 Cardiomyoblasts Cultured in High-Glucose Media". Trabalho apresentado em Annual Meeting of the European Society for Clinical Investigation, 2017.
  44. Katia Santos; José Teixeira; Ricardo Amorim; Fernando Cagide; Fernanda Borges; Paulo J. Oliveira. "New paradigms in anticancer combined therapy: targeting dietary antioxidants to mitochondria". Trabalho apresentado em 49th Annual Meeting of the European Society for Clinical Investigation, 2015.
  45. José Teixeira; Catarina Oliveira; Ricardo Amorim; Tiago Silva; Fernando Cagide; Jorge Garrido; Paulo J. Oliveira; Paula B. Andrade; Fernanda Borges. "Targeting dietary phenolic acids to mitochondria: improving hydroxybenzoic acids antioxidant properties". Trabalho apresentado em 49th Annual Meeting of the European Society for Clinical Investigation, 2015.
  46. Catarina Oliveira; Sofia Benfeito; José Teixeira; Ricardo Amorim; Alexandra Gaspar; Jorge Garrido; Eugénio Uriarte; Paulo J. Oliveira; Fernanda Borges. "Remaking of Dietary Antioxidants: Targeting MitoBEN's to Mitochondria as a New Therapeutic Strategy". Trabalho apresentado em 10° Portuguese National Meeting of Organic Chemistry 1st Portuguese Brazilian Organic Chemist ry Symposium, 2013.
  47. Amorim, Ricardo; Pedro Soares; Tiago Silva; José Teixeira; Jorge Garrido; Fernanda Borges. "Development of Smart Carriers For Delivering Menadione to Mitochondria". Trabalho apresentado em 6° Meeting of young researchers of University of Porto, 2013.
  48. Iva Fernandes; Filipa Costa; Ricardo Amorim; Victor de Freitas ; Nuno Mateus. "Simulated gastrointestinal digestion of Port wines. Effect on human colon cancer cells proliferation". Trabalho apresentado em XXII National Meeting of the Portuguese Chemical Society, 2011.
Tese / Dissertação
  1. "MITOBULLET: ANTIOXIDANT TARGETING OF MITOCHONDRIA TO PREVENT NON-ALCOHOLIC FATTY LIVER DISEASE-INDUCED OXIDATIVE STRESS". Doutoramento, Universidade de Coimbra Instituto de Investigação Interdisciplinar, 2022.
  2. "Development of mitochondria-targeted antioxidants as a therapeutic solution for neurodegenerative diseases". Mestrado, 2013.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2024/06/05 Unlocking Therapeutic Potential: Equisetum ramosissimum Extracts from Portugal's Côa Valley Mitigate Metabolic Liver Disease 58th ESCI Annual Scientific Meeting (ASM)
(Barcelona, Espanha)
2023/11 AntiOxCIN6 potentiates cisplatin anticancer therapy by lowering mitochondrial metabolism while upregulating energetic glycolytic dependence Mitochondria in Aging, Cancer and Cell Death - MAC 2023
MAC organization (Coimbra, Portugal)
2023/03/26 O antioxidante mitocondriotrópico AntiOxCIN4 melhora a função mitocondrial e previne o bloqueio autofágico associado à esteatose hepática em ratinhos alimentados com dieta obesogénica. 19º Congresso Portugês de Diabetes
Sociedade Portuguesa Diabetes (Vilamoura, Portugal)
2023/02/01 The mitochondriotropic antioxidant based on caffeic acid AntiOxCIN6 lowers mitochondrial metabolism while upregulating glycolysis in human HepG2 cells Sociedade Portuguesa de Farmacologia (SPF) Meeting at University of Coimbra
Sociedade Portuguesa de Farmacologia (SPF) (Coimbra, Portugal)
2023/01/12 Mitochondriotropic antioxidant AntiOxCIN4 improves mitochondrial function and prevents Non-Alcoholic Fatty Liver (NAFL)-associated autophagic blockage in Western diet (WD)-fed mice III MAD Meeting
CIBB (Coimbra, Portugal)
2022/06/08 Mitochondriotropic Antioxidants Based on Hydroxycinnamic Acids Activates Nrf2-Mediated Cell Signalling Responses to Oxidative Stress: Implications in Non-Alcoholic Fatty Liver Disease (NAFLD) 56th Annual meeting of the European Society for Clinical Investigation
European Society for Clinical Investigation (Bari, Itália)
2022/01/19 Mitochondria-targeted antioxidant AntiOxCIN4 improved liver steatosis in Western Diet-fed mice by preventing lipid accumulation due to upregulation of fatty acid oxidation and quality control mechanism BEB day
(Coimbra, Portugal)
2021/06/10 Decrypting the Nrf2-dependent antioxidant mechanism of action behind the beneficial effects of the mitochondriotropic cinnamic acid AntiOxCIN4 55th ESCI Annual Scientific Meeting
2020/03/05 Mitochondriotropic Cinnamic Acid Antioxidant Improves Cellular Resistance to Stress MuTaLig COST ACTION CA15135 WG meeting 2020
MuTaLig COST ACTION (Izmir, Turquia)
2019/10/27 Antioxidant hormetic-like properties of AntiOxCIN4, a novel hydroxycinnamic acid-based mitochondria-targeted agent 10th World Congress on Targeting Mitochondria
(Berlin, Alemanha)
2019/06/15 Design and development of multi-target agents for neurodegenerative diseases. Meeting of the Paul Ehrlich Euro-PhD Network - MuTaLig COST action
(Catanzaro, Itália)
2019/06/13 PEGylation technology – the second chance for non-bioavailable drug candidates Meeting of the Paul Ehrlich Euro-PhD Network - MuTaLig COST action
(Catanzaro, Itália)
2019/05/23 Unraveling the mechanism throughout mitochondriotropic cinnamic acid antioxidants increase cellular stress responses in HepG2 cells 53rd Annual Scientific Meeting of the European Society for Clinical Investigation
(Coimbra, Portugal)
2019/02/20 Improving the activity of dietary cinnamic and benzoic acids for the treatment of neurodegenerative disorders 26th Young research fellows meeting
(Paris, França)
2019/02/06 Targeting Phenolic Dietary Antioxidants to Mitochondria to Modulate Redox Signaling and Metabolism Sociedade Portuguesa de Farmacologia (SPF) Meeting
(Porto, Portugal)
2018/10/25 Mitochondria-targeted antioxidants in human hepatic cells: a conceivable therapy for non-alcoholic fatty liver disease 9th World Congress on Targeting Mitochondria
(Berlin, Alemanha)
2018/10/18 Effects of mitochondria-targeted antioxidants in human hepatic cells: a possible therapy for hepatic steatosis? 3nd WG meeting – MuTaLig COST Action
(Valletta, Malta)
2018/10/18 History in the making: development of multi-target-directed ligands for Alzheimer's disease that modulate oxidative stress/mitochondria quality and the cholinergic system 3rd Annual Meeting of COST Action CA15135
(Valletta, Malta)
2018/05/30 Mitochondriotropic cinnamic acid antioxidants increase cellular stress responses in HepG2 cells: Involvement of mitochondrial ROS signaling in a possible therapy for hepatic steatosis? 52nd European Society for Clinical Investigation
(Barcelona, Espanha)
2018/03/15 Mitochondriotropic cinnamic acid antioxidants increase cellular stress responses in HepG2 cells 2nd WG meeting – MuTaLig COST Action.
(Tenerife, Espanha)
2018/03/15 Development of multi-target agents based on hydroxybenzoic acid scaffold endowed with mitochondriotropic antioxidant and cholinesterase inhibitory activity MuTaLig COST action
(Tenerife)
2017/05/26 Effects of different targeting cations on the toxicity profile of mitochondriotropic-hydroxycinnamic antioxidants In MitoPorto: Advances in Mitochondrial Research International Symposium
2017/05/19 MitoK3, a novel mitochondriotropic menadione derivative with cytotoxic effects on cancer cells 51th Annual Scientific Meeting of the European Society for Clinical Investigation
ESCI (Genoa, Itália)
2015/07/03 Targeting dietary hydroxybenzoic acids to mitochondria: A refined strategy to improve Nature V Meeting of the Paul Ehrlich MedChem Euro-PhD Network
(Krakow, Polónia)
2013/09/27 Makeup of natural antioxidants: Design and development of smart carriers to deliver dietary phenolic acids to mitochondria 3rd Meeting of the Paul Ehrlich MedChem Euro- PhD Network
(Cagliari)
2013/09/04 Remaking of Dietary Antioxidants: Targeting MitoBEN's to Mitochondria as a New Therapeutic Strategy 10º Portuguese National Meeting of Organic Chemistry
Sociedade Portuguesa de Química (Lisboa, Portugal)
2013/02/15 Development of Smart Carriers For Delivering Menadione to Mitochondria 6º Meeting of young researchers of University of Porto
(Porto, Portugal)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2023/12 - 2023/12 Participation in the Congress Organizing Committee "Mitochondria in Aging, Cancer and Cell Death" - MAC2023 (2023 - 2023)
Congresso (Membro da Comissão Organizadora)
2019/05/22 - 2019/05/24 Participation in the Congress Organizing Committee of 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (22 to 24th May, 2019, Coimbra, Portugal). (2019/05)

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2017 - Atual Noite Europeia dos Investigadores activities at the Center for Neuroscience and Cell Biology
Oficina (workshop)
 Noite Europeia dos Investigadores
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2019/07/08 - 2019/07/11 12th MiP/MitoEAGLE Training School 2019
Simpósio
 Mitochondrial respiratory physiology: Challenges on data sharing, reproducibility, and interpretation
Universidade de Coimbra, Portugal
2018/07/13 - 2018/07/13 MitoPorto: Mitochondrial Evolution, Metabolism and Disease International Symposium
Simpósio
 MitoPorto: Mitochondrial Evolution, Metabolism and Disease International Symposium
Universidade do Porto Faculdade de Farmácia, Portugal
2017/05/26 - 2017/05/26 MitoPorto: Advances in Mitochondrial Research International Symposium
Simpósio
 In MitoPorto: Advances in Mitochondrial Research International Symposium
Universidade do Porto Faculdade de Farmácia, Portugal

Membro de associação

Nome da associação Tipo de participação
2024/06 - Atual European Association for Cancer Research
2022 - Atual Portuguese Society of Diabetes
2021 - Atual European Association for the Study of the Liver
2018 - Atual European Society for Clinical Investigation

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2024/06/13 - 2024/06/15 Committee Member of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting 2024, Porto, Portugal. (2024/06) (2024/06/13 -2024/06/15)
Membro
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Revisão ad hoc de artigos em revista

Nome da revista (ISSN) Editora
2023/10 - Atual Nutrients (2072-6643) MDPI
2023/07 - Atual Journal of bioenergetics and biomembranes (15736881, 0145479X) Spinger
2021/06/01 - Atual European Journal of Clinical Investigation (0014-2972) Wiley

Tutoria

Tópico Nome do aluno
2017 - Atual Several Bachelor students
2019 - 2019 Visiting Students Vincenzo Piedimonte (Bachelor student) (2019), University of Sannio, Italy..
2018 - 2018 Visiting Students Theresa Thiel (Laboratory Technician) (2018), Mediagnostic, German
Distinções

Prémio

2024 Best poster in fundamental research at 20th Portuguese Diabetes Congress
Sociedade Portuguesa de Diabetologia, Portugal
2024 Tavel grant from Annual Meeting of the ESCI (2024), Barcelona, Spain
European Society for Clinical Investigation, Países Baixos
2023 Tavel grant from Annual Meeting of the ESCI (2023), Prague, Czech Republic
2022 Best poster presentation at 56th Annual Meeting of the ESCI (2022), Bari, Italy
European Society for Clinical Investigation, Países Baixos
2020 2ª Best Oral Presentation - Action CA15135. Izmir, Turkey (2020).
2020 ITC Conference Grant - Action CA15135. Izmir, Turkey (2020).
European Cooperation in Science and Technology, Bélgica
2018 ITC Conference Grant - Action CA15135. Valletta, Malta (2018).
European Cooperation in Science and Technology, Bélgica
2018 Student travel grant - ESCI 2018 - European Society for Clinical Investigation, Barcelona, Spain.
European Society for Clinical Investigation, Países Baixos
2018 ITC Conference Grant - Action CA15135. La Laguna, Tenerife (2018)
2018 Poster Award at the 52nd Annual Meeting of the European Society for Clinical Investigation (2018), Barcelona, Spain.
2017 Doctoral scholarship - Foundation for Science and Technology (FCT), Lisbon, Portugal - SFRH/BD/131070/2017
Associação para a Inovação e Desenvolvimento da FCT, Portugal
2017 Research Fellow (BI) Fellowship - Center for Neurosciences and Cell Biology (CNC), Coimbra, Portugal PTDC-DTP-FTO-2433-2014
2016 Research Fellow (BI) Fellowship - Faculty of Sciences (FCUP), Porto, Portugal PTDC-DTP-FTO-2433-2014
2015 Poster Award at the 49th Annual Meeting of the European Society for Clinical Investigation (2015), Cluj-Napoca, Romania.
European Society for Clinical Investigation, Países Baixos

Outra distinção

2022 Top 5 phD thesis
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal